Hacker News new | past | comments | ask | show | jobs | submit login

I'm not sure what exactly the history of this product is, but my guess is it's a treatment that:

1) Cost a shitload to research

2) Is only applicable to a handful of patients

If this is true, then I don't see what else they should do. If they aren't allowed to sell it at the price they want, then perhaps the research wouldn't have been funded in the first place?




It's a life saving drug of last resorts. And considering the population of India, 'a handful' is too many :).




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: